The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-((2-ethyl-5,7-dimethyl-3H-imidazo[4,5-b]pyridin-3-yl)methyl)-5H-dibenzo[b,f]azepine ID: ALA3809977
PubChem CID: 127043394
Max Phase: Preclinical
Molecular Formula: C25H24N4
Molecular Weight: 380.50
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CCc1nc2c(C)cc(C)nc2n1Cc1ccc2c(c1)C=Cc1ccccc1N2
Standard InChI: InChI=1S/C25H24N4/c1-4-23-28-24-16(2)13-17(3)26-25(24)29(23)15-18-9-12-22-20(14-18)11-10-19-7-5-6-8-21(19)27-22/h5-14,27H,4,15H2,1-3H3
Standard InChI Key: QAYZCHHFHNPKMC-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 33 0 0 0 0 0 0 0 0999 V2000
0.8722 -1.3706 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.1246 1.9313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6509 1.9313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2272 -0.7320 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5854 0.7009 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0183 1.1214 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1241 0.0934 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7970 -1.3083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3486 -1.7444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7943 0.7632 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4672 -0.7164 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5730 -1.7444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0215 -1.2460 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.3330 0.1557 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2272 1.1993 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5661 0.5103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6483 -0.5295 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.7653 -2.6411 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.4186 -1.9745 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8061 -1.5702 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1032 -0.2508 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8856 1.0337 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.4042 0.9751 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1072 -0.3444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3086 -1.6374 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8696 -2.6982 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0416 1.9918 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0851 -2.6577 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0241 -3.8561 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11 1 1 0
1 4 1 0
10 2 1 0
5 3 1 0
2 3 2 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
7 16 1 0
16 17 1 0
17 21 1 0
20 18 1 0
18 19 2 0
19 17 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
25 26 1 0
23 27 1 0
19 28 1 0
28 29 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 380.50Molecular Weight (Monoisotopic): 380.2001AlogP: 5.89#Rotatable Bonds: 3Polar Surface Area: 42.74Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 3.45CX LogP: 5.63CX LogD: 5.63Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.42Np Likeness Score: -0.98
References 1. Fukuda H, Ito S, Watari K, Mogi C, Arisawa M, Okajima F, Kurose H, Shuto S.. (2016) Identification of a Potent and Selective GPR4 Antagonist as a Drug Lead for the Treatment of Myocardial Infarction., 7 (5): [PMID:27190599 ] [10.1021/acsmedchemlett.6b00014 ]